21-year-old MIT dropouts raise $32M at $300M valuation led by Insight

Karun Kaushik and Selin Kocalar weren’t readying to rise a Series A truthful soon. Their AI compliance startup, Delve, which announced a $3 cardinal effect circular successful January, was increasing accelerated and signing customers astatine a dependable clip.

Then, inbound involvement started rolling in, COO Kocalar told TechCrunch.

Delve, which automates regulatory compliance with AI agents, ended up fielding aggregate word sheets, yet closing a $32 cardinal Series A astatine a $300 cardinal valuation. The circular was led by Insight Partners, which took up astir of the round, with information from CISOs astatine Fortune 500 companies.

Insight has been “amazing to enactment with, and we felt they were the close semipermanent spouse for us,” said the COO.

Delve’s caller valuation represents a astir 10x leap from its erstwhile round. Similarly, its lawsuit basal has grown from the 100 companies it reported backmost successful January to implicit 500, galore of them fast-growing AI startups similar precocious minted AI unicorn Lovable, Bland and Wispr Flow.

And portion the two-year-old company, made up of AI researchers from MIT, Stanford, and Berkeley, has seemingly struck golden by utilizing AI to destruct hundreds of hours of manual processes, its communicative began overmuch differently.

Kaushik and Kocalar met arsenic classmates during their freshman twelvemonth astatine MIT. Both had heavy interests successful AI and wellness tech. Kaushik had already scaled a COVID diagnostic strategy to thousands of users during the pandemic. 

In 2023, they began moving connected an AI-powered aesculapian scribe to assistance doctors grip diligent documentation. However, handling delicate healthcare accusation meant they rapidly encountered the costly and time-consuming satellite of HIPAA compliance.

Instead of continuing with the aesculapian scribe, they started gathering tools to assistance different companies get HIPAA compliant faster and much affordably. That pivot got the squad into Y Combinator past year and helped them rise their effect circular from General Catalyst, FundersClub, Soma Capital, and others. The founders dropped retired during their sophomore twelvemonth successful 2023.

What started with HIPAA rapidly expanded. “As our lawsuit basal grew, they started asking for enactment with different frameworks: SOC 2, PCI, GDPR, ISO, fundamentally the full alphabet crockery of compliance,” Kocalar narrated.

L-R: Selin Kocalar (COO) and Karun Kaushik (CEO) Image Credits:Delve

Compliance paperwork tin beryllium indispensable successful everything from launching products to closing endeavor deals. But alternatively of driving growth, its manual enactment tin go a bottleneck.

“Compliance frameworks are standardized. Businesses aren’t,” says CEO Kaushik. “That mismatch is wherefore accepted bundle breaks down and teams autumn backmost to duct-taped workflows crossed email, Slack, and shared drives.”

Delve replaces that busywork with AI agents that tally successful the inheritance (after integrating with customers’ tools) similar interior squad members. These agents cod evidence, constitute reports, update audit logs, and way configuration changes crossed fragmented systems, automating compliance workflows successful existent time.

Kocalar says compliance is conscionable the wedge into broader back-office operations. Long-term, the AI startup wants to automate a cardinal hours of different enactment — yet expanding into adjacent areas similar cybersecurity, risk, and interior governance.

Insight Partners’ involvement reflects this roadmap.

“Since compliance touches each portion of however a concern runs, from scaling operations to closing deals to gathering lawsuit trust, modernizing this relation volition modernize the full organization,” said Praveen Akkiraju, managing manager astatine Insight. “That’s what makes Delve’s attack truthful important.”

Still, the startup won’t beryllium without competition. Several AI companies are emerging with agents to automate concern workflows. In addition, larger AI labs similar OpenAI are releasing general-purpose agents susceptible of performing analyzable tasks.

That said, Kocalar says these developments are a validation, not a threat, to Delve’s business. She points to the company’s domain extent successful opposition to much general-purpose agents.

“We’re positioning ourselves to amended arsenic AI advances and labs rotation retired much blase agentic technologies. But what genuinely sets america isolated is the deep, domain-specific cognition we’re gathering into the platform,” she said. “Compliance is ever shifting arsenic caller regulations look and existing ones evolve, with companies interpreting them successful antithetic ways. That’s wherever Delve stands out.”